Skip to Content

Tag: Orsini


Also Noted

Orsini tapped as exclusive partner on AVLAYAH

April 22, 2026HME News Staff

ELK GROVE VILLAGE, Ill. – Orsini, a provider of rare disease pharmacy solutions, is the exclusive specialty pharmacy partner for Denali Therapeutics' AVLAYAH, an FDA-approved enzyme replacement therapy for the treatment of neurologic manifestations of Hunter syndrome (mucopolysaccharidosis type II, or MPS II) when initiated in presymptomatic or symptomatic pediatric patients weighing at least 5 kg prior to advanced neurologic impairment. As part of this program, Orsini will provide comprehensive...

Denali Therapeutics, Orsini, specialty pharmacy


Read Full Articlered right arrow icon